Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples